PMID- 22525626
OWN - NLM
STAT- MEDLINE
DCOM- 20120813
LR  - 20191210
IS  - 1646-0758 (Electronic)
IS  - 0870-399X (Linking)
VI  - 24
IP  - 5
DP  - 2011 Sep-Oct
TI  - [Club drugs].
PG  - 739-56
AB  - Club drugs are the following substances: Methylenedioxymethamphetamine (MDMA); 
      Methamphetamine; Lysergic Acid Diethylamide (LSD); Ketamine; 
      Gamma-hydroxybutyrate (GHB) and Flunitrazepam. These substances are mainly used 
      by adolescents and young adults, mostly in recreational settings like dance clubs 
      and rave parties. These drugs have diverse psychotropic effects, are associated 
      with several degrees of toxicity, dependence and long term adverse effects. Some 
      have been used for several decades, while others are relatively recent substances 
      of abuse. They have distinct pharmacodynamic and pharmacokinetic properties, are 
      not easy to detect and, many times, the use of club drugs is under diagnosed. 
      Although the use of these drugs is increasingly common, few health professionals 
      feel comfortable with the diagnosis and treatment. The authors performed a 
      systematic literature review, with the goal of synthesising the existing 
      knowledge about club drugs, namely epidemiology, mechanism of action, detection, 
      adverse reactions and treatment. The purpose of this article is creating in 
      Portuguese language a knowledge data base on club drugs, that health 
      professionals of various specialties can use as a reference when dealing with 
      individual with this kind of drug abuse.
FAU - Guerreiro, Diogo Frasquilho
AU  - Guerreiro DF
AD  - Departamento de Psiquiatria e Saude Mental, Hospital de Santa Maria, Lisboa, 
      Portugal.
FAU - Carmo, Ana Lisa
AU  - Carmo AL
FAU - da Silva, Joaquim Alves
AU  - da Silva JA
FAU - Navarro, Rita
AU  - Navarro R
FAU - Gois, Carlos
AU  - Gois C
LA  - por
PT  - Journal Article
PT  - Review
PT  - Systematic Review
TT  - Club drugs: Um Novo Perfil de Abuso de Substancias em Adolescentes e Jovens 
      Adultos.
DEP - 20111229
PL  - Portugal
TA  - Acta Med Port
JT  - Acta medica portuguesa
JID - 7906803
RN  - 0 (Illicit Drugs)
RN  - 44RAL3456C (Methamphetamine)
RN  - 620X0222FQ (Flunitrazepam)
RN  - 690G0D6V8H (Ketamine)
RN  - 7G33012534 (Sodium Oxybate)
RN  - 8NA5SWF92O (Lysergic Acid Diethylamide)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
CIN - Acta Med Port. 2012 Jan-Feb;25(1):60; author reply 60. PMID: 22883253
MH  - Adolescent
MH  - Flunitrazepam/adverse effects/pharmacology
MH  - Humans
MH  - *Illicit Drugs/adverse effects/pharmacology
MH  - Ketamine/adverse effects/pharmacology
MH  - Lysergic Acid Diethylamide/adverse effects/pharmacology
MH  - Methamphetamine/adverse effects/pharmacology
MH  - N-Methyl-3,4-methylenedioxyamphetamine/adverse effects/pharmacology
MH  - Sodium Oxybate/adverse effects/pharmacology
MH  - *Substance-Related Disorders/diagnosis/therapy
MH  - Young Adult
EDAT- 2012/04/25 06:00
MHDA- 2012/08/14 06:00
CRDT- 2012/04/25 06:00
PHST- 2009/06/15 00:00 [received]
PHST- 2010/03/01 00:00 [accepted]
PHST- 2012/04/25 06:00 [entrez]
PHST- 2012/04/25 06:00 [pubmed]
PHST- 2012/08/14 06:00 [medline]
PST - ppublish
SO  - Acta Med Port. 2011 Sep-Oct;24(5):739-56. Epub 2011 Dec 29.